Product NDC: | 63323-306 |
Proprietary Name: | Tobramycin |
Non Proprietary Name: | TOBRAMYCIN SULFATE |
Active Ingredient(s): | 40 mg/mL & nbsp; TOBRAMYCIN SULFATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-306 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065122 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051123 |
Package NDC: | 63323-306-55 |
Package Description: | 25 VIAL in 1 TRAY (63323-306-55) > 2 mL in 1 VIAL |
NDC Code | 63323-306-55 |
Proprietary Name | Tobramycin |
Package Description | 25 VIAL in 1 TRAY (63323-306-55) > 2 mL in 1 VIAL |
Product NDC | 63323-306 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TOBRAMYCIN SULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20051123 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | TOBRAMYCIN SULFATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |